Sort
11,323 grants matching “glioblastoma”
Project 4-Monika Rak
$250,347Monika Rak · Lsu Health Sciences Center · P20 · FY2022 · GM
Project 4-Monika Rak
$250,347Monika Rak · Lsu Health Sciences Center · P20 · FY2024 · GM
Project 4-Monika Rak
$250,347Monika Rak · Lsu Health Sciences Center · P20 · FY2023 · GM
Characterizing inhibitors of tyrosine protein kinase ABL1 (ABL1) in human glioblastoma
$250,290Juan Marugan · National Center For Advancing Translational Sciences · ZIA · FY2019 · TR
Novel Reporters and Delivery Vehicles
$250,277Xandra Owens Breakefield · Massachusetts General Hospital · P50 · FY2010 · CA
An engineered oncolytic herpes virus expressing a full-length α-CD47 mAb for the treatment of GBM
$250,210Michael A Caligiuri · Beckman Research Institute/City Of Hope · U19 · FY2024 · CA
Nanostructured Matrices for Cancer Cell Biology
$250,020Milan Mrksich · Northwestern University At Chicago · U54 · FY2013 · CA
Metallofullerene Nanoplatform for Imaging & Treatment
$250,000John D Wilson · Virginia Commonwealth University · R01 · FY2009 · CA
IND:138100. A phase I and surgical cohort Study of PTC596 in newly diagnosed children with DIPG and high-grade gliomas
$250,000Maryam Fouladi · Research Inst Nationwide Children'S Hosp · R01 · FY2022 · FD
IND:138100. A phase I and surgical cohort Study of PTC596 in newly diagnosed children with DIPG and high-grade gliomas
$249,999Maryam Fouladi · Research Inst Nationwide Children'S Hosp · R01 · FY2021 · FD
Sequence variation in mtDNA and extreme survival in glioblastoma
$249,944Kathleen M Egan · H. Lee Moffitt Cancer Ctr & Res Inst · R21 · FY2017 · CA
Targeting Translation Control in Malignant Glioma
$249,873Matthias Gromeier · Duke University · R01 · FY2012 · CA
A multimodal single-cell approach to developing personalized combinatorial treatments for glioblastoma
$249,832Allegra Adele Petti · Massachusetts General Hospital · R21 · FY2024 · CA
PRODUCTION OF ALTERNATIVE FGF RECEPTOR FORMS IN TUMORS
$249,791Gilbert J. Cote · University Of Tx Md Anderson Can Ctr · R01 · FY2008 · CA
PRODUCTION OF ALTERNATIVE FGF RECEPTOR FORMS IN TUMORS
$249,791Gilbert J. Cote · University Of Tx Md Anderson Can Ctr · R01 · FY2010 · CA
PRODUCTION OF ALTERNATIVE FGF RECEPTOR FORMS IN TUMORS
$249,791Gilbert J. Cote · University Of Tx Md Anderson Can Ctr · R01 · FY2007 · CA
PRODUCTION OF ALTERNATIVE FGF RECEPTOR FORMS IN TUMORS
$249,791Gilbert J. Cote · University Of Tx Md Anderson Can Ctr · R01 · FY2009 · CA
Boronated nucleosides for neutron capture therapy of brain tumors
$249,684Werner Tjarks · Ohio State University · R01 · FY2011 · CA
Boronated nucleosides for neutron capture therapy of brain tumors
$249,631Werner Tjarks · Ohio State University · R01 · FY2012 · CA
The USC-JHU Cancer Epigenome Characterization Center
$249,560Daniel Joseph Weisenberger · University Of Southern California · U24 · FY2014 · CA
THM1 modulation of GLI2 activation in cystic kidney disease
$249,450Pamela Vivian Tran · Brigham And Women'S Hospital · R21 · FY2010 · DK
Development of drug product to support a Phase 0/1b dose escalation trial of MT-125 in recurrent high grade gliomas
$249,417Michael J Brownstein · Myosin Therapeutics Inc. · SB1 · FY2025 · CA
Enhanced intra-arterial drug delivery to the brain after blood brain barrier opening: comparison between osmotic and MRI-guided focused ultrasound opening techniques
$249,347Monica Smith Pearl · Children'S Research Institute · R21 · FY2021 · NS
Genetically engineered mouse models
$249,241Alain Charest · Massachusetts General Hospital · P01 · FY2015 · CA
Genetically engineered mouse models
$249,154Alain Charest · Massachusetts General Hospital · P01 · FY2014 · CA